Recurrent Atrial Fibrillation Market Growth, Size, Forecast 2027 - PowerPoint PPT Presentation

About This Presentation

Recurrent Atrial Fibrillation Market Growth, Size, Forecast 2027


Market Size – USD 9.51 billion in 2019, Market Growth - CAGR of 13.2%, Market Trends – Advancements in device technology. – PowerPoint PPT presentation

Number of Views:1
Slides: 13
Provided by: Jannashar


Transcript and Presenter's Notes

Title: Recurrent Atrial Fibrillation Market Growth, Size, Forecast 2027

Recurrent Atrial Fibrillation Market Size Worth
USD 25.93 Billion by 2027
Market Size USD 9.51 billion in 2019, Market
Growth - CAGR of 13.2, Market Trends
Advancements in device technology.
Our Model
Market Analysis
Financial Analysis
Distribution Channel Analysis
Brand Analysis
Custom Market Intelligence
Competitor Analysis
Product Analysis
Custom Research
Demand Analysis
Risk Analysis
Business Plan Parameters
End Use Analysis
Demand Availability Analytics
Market Entry Strategy
Restructuring Revival
New Product Strategy
Product Planning / Strategy
SWOT Analysis
Marketing / Distribution Channel Feasibility
Customer Identification Survey
Competitive Landscape / MA Feasibility
Industries We Cater to
Market Summary
The global Recurrent Atrial Fibrillation
Market is expected to reach USD 25.93 Billion by
2027, according to a new report by Emergen
Research. The increasing incidence of recurrent
atrial fibrillation is majorly associated with
recurrent paroxysmal atrial fibrillation
patients, with the occurrence of a family history
of AFib, high blood pressure, sleep apnea,
overuse of stimulants, alcohol consumption,
obesity, thyroid disorders, diabetes, lung
disease, severe infections, and stress. Factors
driving this market include augmenting incidence
rate of recurrent atrial fibrillation, new
product launches for effective treatment of
recurrent events, and improved reimbursement
scenarios for recurrent AFib treatment drugs
along with technological advancements are
expected to become the most common growth factors
globally in the coming years. Moreover,
healthcare experts from the University of
Pennsylvania have estimated that patients
admitted to intensive care units for COVID-19
treatment are more likely to suffer from
arrhythmia and atrial fibrillation.
Market Summary
Some Key Highlights From the Report In January
2019, Abbott announced the acceptance of the
TactiCath Touch Force Ablation Catheter by the
FDA. Such winning tactics of leading companies in
the market for atrial fibrillation products are
often adopted by national and local
companies. The prevalence of AFib ranges between
2.7 million and 6.1 million in the U.S. alone and
is estimated to reach 12.1 million by the year
2030, according to the statistics of the Center
for Disease Control. Similar incidence rates are
observed in other regions as well, indicating
potential growth in the target industry. Recently
, in December 2019, the opening generic version
of the blood thinner Eliquis received approval by
the U.S. FDA. The drug is anticipated to provide
quality treatment alternatives at affordable
prices, especially for recurrent AFib patients,
by reducing the risk of recurrence. Key
participants contributing significant market
shares in the industry growth includes Johnson
Johnson, Medtronic Plc, Abbott Laboratories,
Microport Scientific Corporation, Atricure Inc.,
Boston Scientific Corporation, St. Jude Medical,
Inc., Siemens AG, Koninklijke Philips N.V.,
AstraZeneca, Boehringer Ingelheim, Bristol-Myers
Squibb, Daiichi Sankyo, and GlaxoSmithKline. Requ
est Free Sample Copy_at_ https//www.emergenresearch.
Market Summary
Emergen Research has segmented the global
microfluidics market based on material type,
application, component, and region Material
Type Outlook (Revenue, USD Billion
2019-2030) Polymer Silicone Glass Others Applicati
on Outlook (Revenue, USD Billion
2019-2030) Point-of-Care Testing (POCT)
Diagnostics Drug Delivery Systems Pharmaceutical
and Biotechnology Research Clinical
Diagnostics Others Components Outlook (Revenue,
USD Billion 2019-2030) Microfluidic
Chips Micropumps Microneedles Others Read More_at_
Parameter Details
Market Size Estimation Period 2022-2030
Base Year Considered 2021
Historical Data 2019-2020
Forecast Period 2022-2030
Quantitative Units Revenue in USD million CAGR from 2020 to 2028
Segments Covered Types, Application, End-Users, Regions more.
Countries Included The U.S., Germany, U.K., Italy, China, India, Japan, Brazil
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Regions Scope North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Customization Scope 10 hours of free customization expert consultation
Pricing and Purchase Options Explore Different Purchase Options Request for Discount to Avail New Year Discount
Regional Share Dynamics
Latest published reports from the Healthcare
Sector by Emergen Research https//www.prnewswir
rch-895204874.html https//
search-893944076.html https//
mergen-research-841359781.html https//www.prnews
About Us
At Emergen Research, we believe in advancing with
technology. We are a growing market research and
strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially
market-disrupting technologies that are predicted
to become more prevalent in the coming
decade. Our expertise umbrellas the
technological environment of all major
industries, and our services help you map your
actions to ensure optimal yield. Our analysts
utilize their market proficiency to offer
actionable insights that help our clients
implement profitable strategies and optimize
their return on investment. Our services are
wide-ranging, right from technological
environment analysis to technological profiling
that highlights the existing opportunities in the
market you can capitalize on to stay ahead of
your competitors.
Lets Talk Contact Information
Reach out to us and our Research Executives will
ensure you get the report that meets all your
requirements and address all your concerns.
14671 110 Avenue, Surrey, British Columbia, V3R2A9
1 (604) 757-9756
Write a Comment
User Comments (0)